Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Rifkind

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
British Medical Journal|August 27, 2010
Sedimentation Rate of Stored Blood, using Sequestrene as the AnticoagulantI D Melville, B M Rifkind
Endocrinology and Metabolism Clinics of North America|June 1, 1990
Does lowering serum cholesterol levels lower coronary heart disease risk?J E Rossouw, B M Rifkind
Archives of Surgery (Chicago, Ill. : 1960)|January 1, 1978
Testing the lipid hypothesis. Clinical trialsB M Rifkind, R I Levy
European Journal of Clinical Pharmacology|January 1, 1991
The Lipid Research Clinics Coronary Primary Prevention Trial: design, results, and implicationsJ L Probstfield, B M Rifkind
Circulation|November 1, 1980
The structure, function and metabolism of high-density lipoproteins: A status reportR I Levy, B M Rifkind
Minerva Medica|September 26, 1971
[Evaluation of clofibrate therapy in peripheral arteriopathy]T B Begg, B M Rifkind
JAMA|December 19, 1990
Cholesterol reduxB M Rifkind, L D Grouse
JAMA|May 26, 1998
Of designer drugs, magic bullets, and gold standardsB M Rifkind, J E Rossouw
European Heart Journal|August 1, 1989
Cholesterol and coronary heart disease prevention--a transatlantic consensusJ G Brook, B M Rifkind
Cardiovascular Clinics|January 1, 1974
Does hypolipidemic therapy prevent coronary heart disease?B M Rifkind, R I Levy
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
British Medical Journal|August 27, 2010
Sedimentation Rate of Stored Blood, using Sequestrene as the AnticoagulantI D Melville, B M Rifkind
Endocrinology and Metabolism Clinics of North America|June 1, 1990
Does lowering serum cholesterol levels lower coronary heart disease risk?J E Rossouw, B M Rifkind
Archives of Surgery (Chicago, Ill. : 1960)|January 1, 1978
Testing the lipid hypothesis. Clinical trialsB M Rifkind, R I Levy
European Journal of Clinical Pharmacology|January 1, 1991
The Lipid Research Clinics Coronary Primary Prevention Trial: design, results, and implicationsJ L Probstfield, B M Rifkind
Circulation|November 1, 1980
The structure, function and metabolism of high-density lipoproteins: A status reportR I Levy, B M Rifkind
Minerva Medica|September 26, 1971
[Evaluation of clofibrate therapy in peripheral arteriopathy]T B Begg, B M Rifkind
JAMA|December 19, 1990
Cholesterol reduxB M Rifkind, L D Grouse
JAMA|May 26, 1998
Of designer drugs, magic bullets, and gold standardsB M Rifkind, J E Rossouw
European Heart Journal|August 1, 1989
Cholesterol and coronary heart disease prevention--a transatlantic consensusJ G Brook, B M Rifkind
Cardiovascular Clinics|January 1, 1974
Does hypolipidemic therapy prevent coronary heart disease?B M Rifkind, R I Levy
Pageof 9